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Purpose: Previously we demonstrated expression and localization of carnitine/organic cation transporters, OCTN1 and
OCTN2, in human corneal and conjunctival epithelia. The present study aimed to examine the characteristics of L-carnitine
transporters in cultured human limbal corneal (HCLE) and conjunctival epithelial (HCjE) cells.
Methods: Time-course, Na+-dependence, kinetics, energy- and pH- dependence of L-carnitine transport were investigated
by monitoring L-[3H]carnitine uptake into HCLE and HCjE cells. To determine the specificity of action, competition and
inhibition studies were performed.
Results: The uptake of L-carnitine into HCLE and HCjE cells was saturable and time-dependent. An Eadie-Hofstee plot
showed two distinct components: a high- and a low- affinity carnitine transport system in HCLE and/or HCjE cells. L-
carnitine transport was significantly inhibited by the metabolic inhibitors (sodium azide, dinitrophenol, iodoacetic acid).
The L-carnitine analogs (D-carnitine, acetyl-L-carnitine and γ-butyrobetaine), tetraethylammonium (TEA), 2-amino-2-
norbornane carboxylic acid (BCH), strongly inhibited uptake of L-[3H]carnitine. Uptake of L-[3H]carnitine also required
the presence of Na+ in the external medium and the uptake activity was maximal at pH 5.5. The anti-OCTN2 antibody
blocked L-carnitine uptake in both HCLE and HCjE cells whereas the anti-OCTN1 antibody did not significantly block
L-carnitine uptake.
Conclusions: L-carnitine is transported into HCLE and HCjE cells by an active carrier mediated transport system that is
time-, Na+-, energy- and pH- dependent. The carnitine/organic cation transporter OCTN2 appears to play a dominant role
in this process.
Dry  eye  syndrome  (DES)  can  result  in  epithelial
desiccation and ocular surface irritation. These symptoms can
greatly affect the quality of life for affected patients. One of
the key factors in dry eye is an increase in tear osmolarity.
This increase in osmolarity can adversely affect cells causing
cell  shrinkage  and  eventual  death.  To  compensate  for
hypertonic conditions, several compatible solutes have been
incorporated into topical formulations for the treatment and
management  of  dry  eye  syndrome.  These  are  organic
compounds that work like electrolytes to balance osmotic
pressure, yet do not interfere with cellular metabolism, thus
aiding survival of organisms under extreme osmotic stress. L-
carnitine is one such compatible solute, due to its documented
osmoregulatory  activities  [1].  L-carnitine  has  been
demonstrated  as  an  osmoprotectant  against  hyperosmotic
stress of corneal epithelial cells in vitro [2,3]. Further, the
topical use of L-carnitine has been demonstrated to result in
rapid and consistent improvements in the signs and symptoms
of dry eye patients [4]. These observations suggest that L-
carnitine may play a homeostatic role in the eye, in addition
to  its  well  known  role  in  β-oxidation  of  fatty  acids  by
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facilitation  of  transport  of  long-chain  fatty  acids  into  the
mitochondria as acylcarnitine esters [5,6]. This is consistent
with the findings of others who have demonstrated lower
carnitine levels in patients with dry eye syndrome than in
healthy  subjects  [7].  Pescosolido  and  colleagues  [7]
speculated that an imbalance in the concentration of carnitine
molecules in the tear film may be partially responsible for the
damage to ocular cells exposed to the hypertonic tear film
found in dry eye syndrome.
Topically  applied  L-carnitine  is  actively  taken  up  by
ocular cells in animal models [8,9]. Further evidence suggests
the existence of a carrier-mediated organic cation transport
process in the rabbit conjunctiva that mediates absorption of
organic amines, although the underlying mechanisms have yet
to be fully elucidated [8,9]. Previously, we have reported the
presence of organic cation/carnitine transporters, OCTN1 and
OCTN2, in human corneal and conjunctival epithelial cells,
as well as rabbit corneal and conjunctival epithelium [10]. We
have  further  demonstrated  that  OCTN1  and  OCTN2  are
predominately localized in the apical membrane of these cells
[10].  However,  the  mechanism  of  facilitation  of  carnitine
transport  in  corneal  and  conjunctival  epithelium  requires
clarification.
Together  with  the  organic  cation  and  organic  anion
transporters  (OCTs  and  OATs),  the  OCTN  transporters
(organic cation transporter novel type) belong to the SLC22A
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1823family within the solute carrier (SLC) superfamily [11]. The
organic cation transporter (OCTN) subfamily comprises three
members; OCTN1, OCTN2, and OCTN3 that transport the
organic cations, L-carnitine, and acylcarnitines [12], differing
in  their  affinity  and  capacity  for  compound  transport,
energization of transport, and sensitivity to inhibitors [11,
13-16].  OCTN1  (SLC22A4)  has  been  functionally
demonstrated  as  a  multispecific,  bidirectional,  and  pH-
dependent organic cation transporter, presumably energized
by a proton antiport mechanism that transports L-carnitine in
a  Na+-dependent  manner  [17,18].  OCTN2  (SLC22A5)  is
unique in that it transports carnitine with high affinity in a Na
+-dependent manner and transports organic cations in a Na+-
independent manner [15,19]. The OCTN2 carnitine-specific
transport  system  has  been  documented  in  human  kidney,
skeletal  muscle,  heart,  and  placenta  [14,20].  OCTN3
(SLC22A21)  meditates  L-carnitine  transport  in  a  Na+-
independent manner and has higher affinity for L-carnitine
than OCTN1 or OCTN2 [17]. In addition, L-carnitine can also
be  transported  by  the  CT2  (human  carnitine  transporter,
SLC22A16) [21] and by ATBo,+ (amino acid transporter B0,+,
SLC6A14)  [22],  which  are  Na+-independent  and  Na+-
dependent transporters respectively. ATBo,+ is reported to be
a low-affinity transporter for L-carnitine [22].
To  further  our  previous  investigation  in  which  we
demonstrated the expression of L-carnitine transport proteins
in corneal and conjunctival epithelium [10], the present study
extends  the  functional  characterization  of  L-carnitine
transporters through examination of the sodium-, energy- and
pH-dependence,  and  substrate  specificity  of  the  transport
process.
METHODS
Materials:  Cell  culture  media  (keratinocyte  serum-free
medium, K-SFM), media supplements, and epidermal growth
factor (EGF) were purchased from Invitrogen-Gibco (Grand
Island,  NY).  L-carnitine,  D-carnitine,  acetyl-L-carnitine,
tetraethylammonium  (TEA),  2-amino-2-norbornane
carboxylic  acid  (BCH),  γ-butyrobetaine,  sodium  azide,
dinitrophenol, iodoacetic acid, and Triton X-100 were from
Sigma Chemical Co. (St Louis, MO). L-[methyl-3H]carnitine
hydrochloride  (specific  activity  of  3.07  TBq/mmol)  was
obtained from GE Healthcare UK Limited, Amersham Place,
Little  Chalfont  (Buckinghamshire,  UK).  Goat  anti-human
OCTN1 polyclonal antibody and goat anti-human OCTN2
polyclonal antibody were from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA). All other reagents were of analytical
grade.
Cell culture: Immortalized human corneal-limbal epithelial
(HCLE) and human conjunctival epithelial (HCjE) cell lines
derived from primary cultures of HCLE and HCjE cells (a
kind  gift  from  Ilene  Gipson’s  laboratory,  Schepens  Eye
Research Institute, Boston, MA) were used. HCLE and HCjE
cells were cultured as described previously [23,24]. Briefly,
cells were maintained on plastic at 2×104/cm2 in K-SFM,
supplemented with 25 μg/ml bovine pituitary extract, 0.2 ng/
ml EGF and 0.4 mM CaCl2 and were grown at 37 °C in a 5%
carbon dioxide atmosphere. To enhance nutrient composition,
the cultures were switched at approximately 50% confluence
to a 1:1 mixture of K-SFM and low calcium DMEM/F12
(Invitrogen) to achieve confluence.
Transport study: HCLE and HCjE cells were grown on 24-
well  tissue  culture  plates  at  an  initial  seeding  density  of
5×105  cells/well  to  80%–90%  confluence.  Following  the
removal of media, the cells were pre-incubated with uptake
buffer (25 mM Tris/HEPES, 140 mM NaCl, 5.4 mM KCl,
1.8 mM CaCl2, 0.8 mM MgSO4, and 5 mM glucose, pH 7.4)
at  37  °C  in  air  for  60  min.  L-[3H]  carnitine  (L-
[methyl-3H]carnitine  hydrochloride)  was  added  to  the
medium in the presence or absence of unlabeled substrates of
varying concentrations. Non-specific uptake for the labeled
substrates was determined using 100 fold excess unlabeled L-
carnitine  (up  to  10  mM  due  to  solubility).  To  obtain  the
specific uptake, the nonspecific uptake values were subtracted
from the total uptake values. At a given incubation time, the
incubation medium was removed, and the cells were rinsed
three times in ice-cold PBS for 30 s each. The cell membranes
were then solubilized using 0.1 M NaOH and 0.1% Triton
X-100,  and  aliquots  were  removed  for  liquid  scintillation
counting (disintegrations/min). The cellular protein content
was  measured  using  a  LavaPep  peptide  quantification  kit
(Fluorotechnics Pty Limited, Sydney, Australia) with a BSA
standard.  For  Na+-free  experiments,  NaCl  was  substituted
with equimolar choline chloride in the above buffer [17].
The energy-dependence of L-[3H]carnitine uptake was
investigated  by  pre-treating  the  cells  with  metabolic
inhibitors, sodium azide (10 mM), dinitrophenol (10 mM), or
iodoacetic acid (10 mM) for 30 min followed by incubation
with 24 nM L-[3H]carnitine for 30 min.
To  study  the  pH-dependence  of  the  L-[3H]carnitine
uptake, cells were pre-incubated for 60 min in the uptake
buffer  at  pH  5.5,  6.5,  7.4,  and  8.5,  respectively.  L-
[3H]carnitine (24 nM) was then added and incubation was
continued for 30 min.
Substrate  specificity  was  examined  by  pre-incubating
cells for 60 min in the uptake buffer followed by further
incubation of cells for 30 min with L-[3H]carnitine (24 nM)
in the absence (control) or presence of 0.5 and 1.0 mM of L-
carnitine  structural  analogs  (unlabeled  L-carnitine,  D-
carnitine, acetyl-L-carnitine, or γ-butyrobetaine), or 0.1 and
1.0 mM tetraethylammonium (TEA, a known organic cation
substrate for OCTN2) [25], and 0.1 and 1.0 mM 2-amino-2-
norbornane carboxylic acid (BCH, a known specific inhibitor
for ATB0,+) [22].
For blocking experiments, cells were pre-incubated for
60 min with uptake buffer in the absence (control) or presence
of OCTN1 (1:500) and/or OCTN2 (1:500) antibody at 37 °C;
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1824L-[3H]carnitine (24 nM) was then added and the incubation
was continued for 30 min.
mRNA expression: mRNA expression was investigated as
previously reported [10]. Briefly, total RNA was extracted
from cultured HCLE and HCjE cells using the SV Total RNA
Isolation  System  (Promega,  Madison,  WI).  RT–PCR  was
performed  using  SuperScript  One-step  RT–PCR  with
Platinum Taq System (Invitrogen). Purity and integrity of
RNA was verified using an ultraviolet spectrophotometer and
agarose gel visualization of ribosomal bands, respectively.
Transcripts  for  ATB0,+  were  amplified  using  the  primers
described in Table1. The transcripts for OCTN1 or OCTN2
were amplified as previously reported [10] using the primers
listed  in  Table  1.  A  control  housekeeping  gene  β-actin
(ACTB) was amplified under the same conditions [10]. The
PCR products were separated by electrophoresis on a 1.2%
agarose gel and analyzed by Gel-Pro analyzer version 3.1
software (Media Cybernetics, Silver Spring, MD). The ratio
of integrated density of target genes over ACTB was used to
normalize the relative mRNA expression. The PCR products
were purified using Wizard SV Gel and PCR Clean-up System
(Promega). The identity of each PCR product was verified by
DNA  sequencing  (Department  of  Biologic  Sciences,
Macquarie  University  DNA  Analysis  Facility,  Sydney,
Australia).
Data  analysis:  The  uptake  experiments  were  routinely
executed in duplicate and each experiment was repeated three
to four times. The results are expressed as mean ±SD. The
apparent kinetic parameters, Km and the maximal transport
rate (Vmax), of carnitine uptake by HCLE and HCjE cells were
estimated by nonlinear regression curve fitting according to
the  following  Michaelis–Menten  type  equation  with  two
saturable  transport  components,  where  v  and  [s]  are  the
velocity of substrate uptake and the substrate concentration
respectively and indices 1 and 2 indicate the high- and low-
affinity components respectively;
v = Vmax1  ×   s /(Km1 + s ) + Vmax2  ×   s /(Km2 + s )
The  Km  and  V  max  values  were  determined  from
Lineweaver-Burk  plots.  Student’s  unpaired  t  -test  was
performed using commercial computer software (SPSS; SPSS
Inc.,  Chicago,  IL).  Post  hoc  multiple  comparisons  were
analyzed incorporating the Bonferroni correction. Statistical
significance was set at p<0.05.
RESULTS
Time course and Na+ dependence of L-[3H] carnitine uptake
by HCLE and HCjE cells: L-[3H] carnitine uptake in both
HCLE (Figure 1A) and HCjE (Figure 1B) cells increased in a
time-dependent manner, and appeared to be linear up to at
least 90 min. When Na+ in the uptake buffer was replaced with
choline,  the  uptake  was  decreased  by  90%  (p=0.001).
Consequently, subsequent experiments were performed using
an uptake period of 30 min in the presence of Na+.
Figure 1. Time course and Na+-dependence of L-carnitine uptake.
The uptake of 12nM L-[3H]carnitine by HCLE (A) or HCjE (B) cells
was measured at pH 7.4 and 37 °C in the presence or absence of Na
+.  For  Na+-free  buffer,  NaCl  was  replaced  by  an  equimolar
concentration of choline. Values are the mean±SD (n=4).
TABLE 1. PRIMER SEQUENCES.
Transporter Primer sequence TM (°C) Product size (bp)
ATB0,+ 5’-TGTCTACCTCGGCCTCCTAA-3′ 60 300
  5′-CCAAATCTTCCCTGAATTGC-3′ 60  
OCTN1 5′-CTGGATGCTCCTAATTTACATGG-3′ 49 785
  5’-AGGAGACTCTCTAGAAATGGTTGG-3′ 49  
OCTN2 5′-AGTGGGCTATTTTGGGCTTT-3′ 60 398
  5′-GGTCGTAGGCACCAAGGTAA-3′ 60  
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1825Figure 2. Concentration dependence and the kinetic characteristics
of L-carnitine uptake.   A: Concentration dependence of carnitine
uptake by HCLE or HCjE cells; B and C:  the kinetic characteristics
of L-[3H]carnitine uptake with the Eadie–Hofstee plot indicating
dependence  of  the  uptake  rate  (v)  on  uptake  rate/carnitine
concentration (v/s) for HCLE (B) and HCjE (C) cells, respectively.
HCLE or HCjE cells were pre-incubated for 60 min with uptake
buffer, then different concentrations of L-carnitine were added to the
incubation medium and the uptake was measured for 30 min at pH
7.4 and 37 °C in the presence of Na+. The concentration of L-
[3H]carnitine was kept constant at 24 nM and the concentration of L-
carnitine was varied (range 1-480 μM) by addition of unlabeled L-
carnitine. Values are the mean±SD (n=4).
Kinetics of L-[3H]carnitine uptake in HCLE or HCjE cells:
Carnitine uptake by HCLE or HCjE cells was concentration-
dependent and the uptake appeared to be saturable (Figure
2A). The kinetics of L-[3H]carnitine uptake in HCLE and
HCjE cells were analyzed by fitting the data to the Michaelis–
Menten  models  using  nonlinear  regression  analysis.  The
Eadie-Hofstee plot in which the uptake rate (v) was plotted as
a function of the uptake rate/carnitine concentration ratio (v/
s) clearly indicated two distinct components: a high-affinity
and a low-affinity carnitine transport system in both HCLE
(Figure 2B) and HCjE (Figure 2C) cells. The kinetic analysis
yielded  apparent  Michaelis–Menten  constants  (Km)  of
9.48±2.7 µM and 363.64±34.4 µM for high- and low-affinity
carnitine transport, respectively, in HCLE cells (Table 2), and
9.39±1.3 µM and 196.03±17.1 µM for high- and low- affinity
transport, respectively, in HCjE cells (Table 2). The maximum
transport  activities  (Vmax)  of  0.48±0.09  pmol/h/mg  protein
(high affinity) and 5.1±0.3 pmol/h/mg protein (low affinity)
were estimated for HCLE, and 0.36±0.07 pmol/h/mg protein
(high affinity) and 1.99±0.2 pmol/h/mg protein (low affinity)
for HCjE (Table 2). These results suggest the existence of both
high- and low- affinity L-carnitine transport systems in HCLE
and HCjE cells.
Energy-dependence of L-[3H]carnitine uptake by HCLE and
HCjE cells: Following pretreatment with metabolic inhibitors
sodium azide, dinitrophenol, or iodoacetic acid for 30 min, the
uptake of L-[3H]carnitine was reduced to approximately 80%,
70%, and 30%, respectively (p<0.01), for both HCLE and
HCjE cells (Table 3).
pH - dependence of the uptake of L-[3H]carnitine by HCLE
and HCjE cells: Figure 3 shows the uptake of 24 nM L-
[3H]carnitine by HCLE or HCjE cells in the external uptake
buffer at pH 5.5, 6.5, 7.4, or 8.5. The uptake activity was
highest at pH 5.5 (p=0.005 and p=0.002 for HCLE and HCjE
cells, respectively). The activity was higher at pH 6.5 than pH
7.4  (p=0.002  and  p=0.007  for  HCLE  and  HCjE  cells,
respectively), but no difference was found at pH 7.4 compared
to pH 8.5. No changes in cell morphology were observed at
pH 5.5 and pH 6.5 (data not shown).
Structural analog, organic cation and BCH inhibition on the
uptake of L-[3H]carnitine by HCLE and HCjE cells: As shown
in Table 4, the structural analogs L-carnitine, D-carnitine,
acetyl-L-carnitine and γ-butyrobetaine significantly inhibited
the uptake of L-[3H]carnitine by both HCLE and HCjE cells.
For both cell types, the inhibitory effect of L-carnitine was
slightly greater than that of D-carnitine and acetyl-L-carnitine,
and the effect of γ-butyrobetaine, a precursor of carnitine
biosynthesis, was approximately equal to that of L-carnitine.
No difference was found between D-carnitine and acetyl-L-
carnitine. Inhibition was also concentration dependent. TEA,
a  known  organic  cation  transported  by  OCTN2  [25],  and
BCH,  a  known  specific  inhibitor  for  ATB0,+  [22],  both
significantly inhibited L-[3H]carnitine uptake by HCLE and
HCjE cells in a concentration dependent manner (Table 4).
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1826mRNA expression of ATB0,+: The expression of OCTN1 and
OCTN2 has been reported previously in HCLE and HCjE cells
[10]. The finding in the present study where BCH was found
to inhibit L-[3H]carnitine uptake, suggests that ATB0,+ may be
involved in L-carnitine transport in HCLE and HCjE cells.
The expression of this transporter was detected but at a much
lower level relative to OCTN1 and OCTN2 (Figure 4).
The blocking effect of OCTN1 and OCTN2 antibody on the
uptake of L-[3H]carnitine by HCLE and HCjE cells: As shown
in Figure 5, the anti-OCTN2 antibody blocked L-[3H]carnitine
uptake in both HCLE (p=0.004) and HCjE (p=0.019) cells.
The  anti-OCTN1  antibody,  on  the  other  hand,  did  not
significantly block uptake when compared with the control
group nor did it contribute to blocking in combination with
OCTN2 (Figure 5).
DISCUSSION
Figure  3.  Effect  of  the  pH  of  the  medium  on  the  uptake  of  L-
[3H]carnitine by HCLE or HCjE cells at 37 °C. HCLE or HCjE cells
were pre-incubated for 60 min in uptake buffer of different pH values
at 37 °C; L-[3H]carnitine (24 nM) was then added and incubation
was continued for 30 min. Each value is the mean±SD of results from
three experiments. #p<0.005 for HCLE and 0.002 for HCjE cells
respectively compared with medium at pH 7.4. *p=0.002 for HCLE
and, p=0.007 for HCjE, respectively compared with medium at pH
7.4.
Carnitine transport has been extensively studied in a variety
of human and animal tissues, such as kidney, skeletal muscle,
heart, placenta, brain [20], mammary gland epithelia [11],
liver [26], and rabbit conjunctiva [9]. However, little is known
about the function of carnitine transporters present in ocular
tissues including the corneal and conjunctival epithelia [10].
This  present  study  provides  further  insights  into  the
Figure 4. Relative expression of OCTN1, OCTN2, and ATB0,+ in
human  ocular  epithelial  cells.  Representative  image  of  semi-
quantitative RT PCR -amplified human OCTN1, OCTN2, ATB0,+,
and ACTB products. In the image, Lanes 1,3,5,7 show HCLE product
and Lanes 2,4,6,8 show HCjE product: Lanes 1–2 OCNT1; Lanes 3–
4 OCTN2; Lanes 5–6 ATB0,+; and Lanes 7–8 ACTB.
Figure 5. Blocking effect of OCTN1 and/or OCTN2 antibody on the
uptake of L-[3H]carnitine by HCLE or HCjE cells at 37 °C. HCLE
or  HCjE  cells  were  pre-incubated  for  60  min  in  uptake  buffer
containing  OCTN1  (1:500)  and/or  OCTN2  (1:500)  antibody  at
37 °C; L-[3H]carnitine (24 nM) was then added and incubation was
continued for 30 min. Each value is the mean±SD of results from
three experiments. *p<0.01 compared with the control group.
TABLE 2. DETERMINATION OF KM AND VMAX OF L-[3H]CARNITINE UPTAKE IN HCLE OR HCJE CELLS AT PH 7.4 AND 37 °C.
  HCLE HCjE
Parameters High affinity Low affinity High affinity Low affinity
Km 9.48±2.7 363.64±34.4 9.39±1.3 196.03±17.1
Vmax 0.48±0.09 5.1±0.3 0.36±0.07 1.99±0.2
r2 0.9778 0.9862 0.9933 0.9796
Values are the mean±SD (n=3). Km=Michaelis constant (µM); Vmax=maximum initial transport activity (pmol/h/mg protein);
and r2=goodness of fit (linear-factor).
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1827mechanism of carnitine transport in cultured human ocular
epithelial cells, and the transporters specific for this process.
Our findings indicate that the uptake of L-[3H]carnitine
in both HCLE and HCjE cells is saturable and Na+-dependent
with the uptake profile for both cell lines comprising two
distinct and significantly different components, suggesting
the  existence  of  both  high  and  low  affinity  L-carnitine
transport systems. The high affinity system Km, obtained in
the present study for HCLE and HCjE cell lines (9.48 µM and
9.39 µM, respectively) is similar to that derived for the high
affinity  L-carnitine  transporter,  OCTN2,  in  various  other
tissues; for example, conditionally immortalized rat retinal
capillary endothelial cells (29.0±13.8µM) [27], isolated rat
kidney brush border membrane vesicles (17.4 µM) [28], LLC-
PK1 cells (11.0 µM) [29], and CHO cells with functional
expression of OCTN2 (8.01 µM) [30]. Our values are in good
agreement with the range of 8.01–29 µM reported for the
above studies performed at 37 °C, pH 7.4.
Metabolic  inhibitors  that  uncouple  oxidative
phosphorylation (sodium azide and dinitrophenol) [26], as
well  as  those  that  inhibit  glycolytic  ATP  generation
(iodoacetic acid) reduced the L-[3H]carnitine uptake, further
indicating  that  L-carnitine  is  transported  by  an  energy-
dependent,  active  carrier-mediated  transport  system.  The
uptake activity was also found to be pH-dependent. Since
changes in pH could affect the conformation of the transporter
within the plasma membrane, this could have a direct effect
on  the  transport  of  L-carnitine  [26].  This  pH-dependence
might be ascribed to at least two underlying mechanisms,
including activation by a proton gradient, or by the presence
of a functionally optimal protonated form of the transporter
[16]. The activity demonstrated here is similar to the activity
TABLE 3. ENERGY-DEPENDENCE OF THE UPTAKE OF L-[
3H]CARNITINE BY HCLE OR HCJE CELLS AT PH 7.5 AND 37 °C.
  Relative uptake (% of control)
Compound HCLE HCjE
Sodium azide 80.4±1.8 79.2±1.3
Dinitrophenol 69.1±4.7 63.1±7.6
Iodoacetic acid 27.2±6.3 27.8±3.3
     HCLE or HCjE cells were pre-incubated for 30 min in uptake buffer containing 10 mM of sodium azide, dinitrophenol or
     iodoacetic acid; L-[3H]carnitine (24 nM) was then added and the incubation continued for 30 min. Each value is the percentage
     uptake of L-[3H]carnitine in medium containing sodium azide, dinitrophenol, or iodoacetic acid compared with that in control
     medium without these compounds. Values are the mean±SD of results from four experiments.
TABLE 4. INHIBITORY EFFECT OF STRUCTURAL ANALOGS, ORGANIC CATION AND BCH ON THE UPTAKE OF L-[
3H]CARNITINE
BY HCLE OR HCJE CELLS.
   
Relative uptake (% of control)
  Compound Conc. (mM) HCLE HCjE
L-Carnitine 0.5 34.6±2.4 24.9±2.1
  1 14.9±3.2 11.7±1.5
D-Carnitine 0.5 46.6±3.1 43.9±1.9
  1 14.4±0.6 21.7±1.1
Acetyl-L-Carnitine 0.5 42.1±4.8 37.1±4.9
  1 20.9±4.1 25.6±5.7
γ-Butyrobetaine 0.5 30.2±5.3 27.5±4.8
  1 16.9±3.7 17.4±3.3
TEA 0.1 85.6±4.2 74.9±2.7
  1 48.3±5.1 59.2±1.4
BCH 0.1 87.1±0.7 84.5±4.4
  10 46.5±2.9 63.8±4.3
        HCLE or HCjE cells were pre-incubated for 60 min in uptake buffer at 37 °C; L-[3H]carnitine (24 nM) was then added in the
        absence (control) or presence of L-carnitine, D-carnitine, Acetyl-L-carnitine, γ-Butyrobetaine, TEA and BCH, and the incubation
        continued for 30 min. Data (uptake of L-[3 H]carnitine as a percentage of that in the control) are means±SD of results from three
        experiments. All results were significantly reduced compared to the controls (p<0.01).
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1828of L-carnitine transport in the human placental brush-border
membrane [15], but differs from that reported for cultured
human hepatoma HLF cells, in which the uptake was highest
at pH 7.4 [26]. This variation in optimal pH between different
cell types warrants further investigation.
The involvement of the transporters, OCTN2 or ATB0,+,
in  the  transport  of  carnitine  was  further  confirmed  by
inhibition  (substrate  specific)  studies.  The  concentration-
dependent inhibition studies showed that carnitine transport
activity was reduced by the carnitine analogs (L-carnitine, D-
carnitine,  acetyl-L-carnitine,  and  γ-butyrobetaine)  and
organic cationic compound (TEA). The inhibitory potencies
of these compounds agree with those previously reported for
the inhibition of OCTN2-mediated transport [31,32]. A recent
study  by  Tachikawa  and  colleagues  [33]  found  similar
inhibition with L-carnitine and TEA in their studies across the
inner blood-retinal barrier. They concluded that OCNT2 is
most  likely  involved  in  L-carnitine  transport.  Similar
inhibition was also observed in the OCTN2-transfected HEK
cells [20]. Using polarized monolayers of HCLE and HCjE
cells, we have previously demonstrated that the majority of
carnitine was transported to the apical surface of the cells,
consistent  with  the  localization  of  OCTN2  found
predominantly  on  apical  membrane  of  the  cells  [10].  In
agreement with the findings of others [20], our data here
provide functional characteristic evidence of the OCTN2-
actively mediated L-carnitine transport process for the human
corneal and conjunctival epithelial cells. This may also offer
further support for other reported findings where the uptake
of L-carnitine into ocular tissues is observed [4,8,9].
ATB0,+, on the other hand, is a Na+- and Cl-- coupled
transport system for neutral and cationic amino acids. It is a
low-affinity  transporter  for  L-carnitine  and  is  sensitive  to
BCH at high concentrations (5–10 mM) [22]. In the present
study, we also found that BCH (0.1 and 10 mM) inhibited the
L-[3H]carnitine uptake in HCLE and HCjE cells with greater
inhibition exhibited at higher concentrations. Further, the real-
time PCR analysis detected a low level of ATB0,+ in these cells.
These data suggest that ATB0,+ may also play a role in the L-
carnitine transport process, as has been suggested previously
[22,34]. In contrast to OCNT2, ATB0, + does not transport
acetyl-carnitine, highlighting differential affinities of OCTN2
and ATB0,+ which may dictate independent physiologic roles
[22].
OCTN1 is a pH-dependent organic cation transporter that
transports L-carnitine in a Na+-dependent manner [17,18]. Rat
intestinal  OCTN1,  however,  reportedly  interacts  with  L-
carnitine with low affinity and in a Na+-independent manner
[35].  Conversely,  OCTN2  transports  carnitine  with  high
affinity in a Na+-dependent manner and transports organic
cations in a Na+-independent manner [15,19]. The observed
blocking  of  L-[3H]carnitine  uptake  by  OCTN2-specific
antibodies, but not with OCTN1-specific antibodies, further
supports the hypothesis that OCTN2 plays a major role in the
transport of carnitine in human ocular epithelial cells and
constitutes  the  high  affinity  transport  component.  The
contribution of both OCTN1 and ATB0,+ need to be further
addressed to elucidate the nature of the low affinity kinetic
component.
L-carnitine is present in considerable quantities in the
tears  of  normal  healthy  eyes  [7].  However,  for  dry  eye
patients, the tear carnitine level is reduced significantly [7].
Corrales et al. [2] have shown that L-carnitine can protect
against stress activation of corneal epithelial cells in response
to hyperosmolar stress. We also demonstrated that carnitine
protects corneal epithelial cells from hyperosmolar solution
induced  damage  [3].  Taken  together  these  observations
support the hypothesis that carnitine plays a crucial role in
protecting  ocular  surfaces  from  hyperosmolarity-induced
damage,  thus  contributing  to  the  reduction  of  deleterious
physiologic changes in dry eye. In addition, this present work
provided evidence that carnitine can be actively transported
to the ocular cells in a Na+-dependent manner, potentially
extending  the  application  of  carnitine  not  only  as  a
micronutrient but also as a beneficial compatible solute in
topically  administered  ophthalmic  formulations,  such  as
artificial  tears,  to  enhance  cell  survival  under  hypertonic
conditions.
In  conclusion,  high-  and  low-affinity  L-carnitine
transport occurs in human HCLE and HCjE cells. Consistent
with our previous demonstration of OCTN2 expression in
these cells, the present work provides further evidence of an
active high-affinity transport system for carnitine in the ocular
epithelial cells that is Na+-, pH-, and energy-dependent with
characteristics resembling OCTN2.
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